RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
New Haven, CT · +49 more sites
2 recruiting multiple sclerosis studies with a site in New Haven, CT.
Sponsor: National Cancer Institute (NCI)
New Haven, CT · +49 more sites
Sponsor: Yale University
New Haven, CT
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.